Evidence map›Paper›PMID 38388549›Full record

ArticleScientific reports2024

Predicting the formation of NADES using a transformer-based model.

Lucas B Ayres, Federico J V Gomez, Maria Fernanda Silva, Jeb R Linton, Carlos D Garcia

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lucas B AyresDepartment of Chemistry, Clemson University, 211 S. Palmetto Blvd, Clemson, SC, 29634, USA.
Federico J V GomezFacultad de Ciencias Agrarias, Instituto de Biología Agrícola de Mendoza (IBAM-CONICET), Universidad Nacional de Cuyo, Mendoza, Argentina.
Maria Fernanda SilvaFacultad de Ciencias Agrarias, Instituto de Biología Agrícola de Mendoza (IBAM-CONICET), Universidad Nacional de Cuyo, Mendoza, Argentina.
Jeb R LintonDepartment of Chemistry, Clemson University, 211 S. Palmetto Blvd, Clemson, SC, 29634, USA.
Carlos D GarciaDepartment of Chemistry, Clemson University, 211 S. Palmetto Blvd, Clemson, SC, 29634, USA. cdgarci@clemson.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of natural deep eutectic solvents (NADES) in the pharmaceutical, agricultural, and food industries represents one of the fastest growing fields of green chemistry, as these mixtures can potentially replace traditional organic solvents. These advances are, however, limited by the development of new NADES which is today, almost exclusively empirically driven and often derivative from known mixtures. To overcome this limitation, we propose the use of a transformer-based machine learning approach. Here, the transformer-based neural network model was first pre-trained to recognize chemical patterns from SMILES representations (unlabeled general chemical data) and then fine-tuned to recognize the patterns in strings that lead to the formation of either stable NADES or simple mixtures of compounds not leading to the formation of stable NADES (binary classification). Because this strategy was adapted from language learning, it allows the use of relatively small datasets and relatively low computational resources. The resulting algorithm is capable of predicting the formation of multiple new stable eutectic mixtures (n = 337) from a general database of natural compounds. More importantly, the system is also able to predict the components and molar ratios needed to render NADES with new molecules (not present in the training database), an aspect that was validated using previously reported NADES as well as by developing multiple novel solvents containing ibuprofen. We believe this strategy has the potential to transform the screening process for NADES as well as the pharmaceutical industry, streamlining the use of bioactive compounds as functional components of liquid formulations, rather than simple solutes.

Identifiers

PMID38388549
PMCPMC10883925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.